000858404 001__ 858404
000858404 005__ 20210129235940.0
000858404 0247_ $$2doi$$a10.21769/BioProtoc.2941
000858404 0247_ $$2pmid$$apmid:30069495
000858404 0247_ $$2WOS$$aWOS:000457966200014
000858404 0247_ $$2altmetric$$aaltmetric:52718069
000858404 037__ $$aFZJ-2018-07290
000858404 082__ $$a570
000858404 1001_ $$0P:(DE-HGF)0$$aWördehoff, Michael$$b0
000858404 245__ $$aα-Synuclein Aggregation Monitored by Thioflavin T Fluorescence Assay
000858404 260__ $$aSunnyvale, CA$$bbio-protocol.org$$c2018
000858404 3367_ $$2DRIVER$$aarticle
000858404 3367_ $$2DataCite$$aOutput Types/Journal article
000858404 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1544538066_28835
000858404 3367_ $$2BibTeX$$aARTICLE
000858404 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000858404 3367_ $$00$$2EndNote$$aJournal Article
000858404 520__ $$aStudying the aggregation of amyloid proteins like α-synuclein in vitro is a convenient and popular tool to gain kinetic insights into aggregation as well as to study factors (e.g., aggregation inhibitors) that influence it. These aggregation assays typically make use of the fluorescence dye Thioflavin T as a sensitive fluorescence reporter of amyloid fibril formation and are conducted in a plate-reader-based format, permitting the simultaneous screening of multiple samples and conditions. However, aggregation assays are generally prone to poor reproducibility due to the stochastic nature of fibril nucleation and the multiplicity of modulating factors. Here we present a simple and reproducible protocol to study the aggregation of α-synuclein in a plate-reader based assay.
000858404 536__ $$0G:(DE-HGF)POF3-553$$a553 - Physical Basis of Diseases (POF3-553)$$cPOF3-553$$fPOF III$$x0
000858404 588__ $$aDataset connected to CrossRef
000858404 7001_ $$0P:(DE-Juel1)166306$$aHoyer, Wolfgang$$b1$$eCorresponding author$$ufzj
000858404 773__ $$0PERI:(DE-600)2833269-6$$a10.21769/BioProtoc.2941$$gVol. 8, no. 14$$n14$$pPMC6066150$$tBio-protocol$$v8$$x2331-8325$$y2018
000858404 909CO $$ooai:juser.fz-juelich.de:858404$$pVDB
000858404 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166306$$aForschungszentrum Jülich$$b1$$kFZJ
000858404 9131_ $$0G:(DE-HGF)POF3-553$$1G:(DE-HGF)POF3-550$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lBioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences$$vPhysical Basis of Diseases$$x0
000858404 9141_ $$y2018
000858404 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000858404 920__ $$lyes
000858404 9201_ $$0I:(DE-Juel1)ICS-6-20110106$$kICS-6$$lStrukturbiochemie $$x0
000858404 980__ $$ajournal
000858404 980__ $$aVDB
000858404 980__ $$aI:(DE-Juel1)ICS-6-20110106
000858404 980__ $$aUNRESTRICTED
000858404 981__ $$aI:(DE-Juel1)IBI-7-20200312